摘要
目的:观察认知疗法联合阿戈美拉汀治疗抑郁症患者的疗效。方法:选择本院2018年2月至2019年2月收治的100例抑郁症患者,将全部患者分为对照组(50例)与观察组(50例),对照组患者予以阿戈美拉汀治疗,观察组患者予以认知疗法联合阿戈美拉汀治疗。对比两组患者HAMD、SDRS评分情况、以及临床治疗效果。结果:治疗前,两组患者HAMD、SDRS评分无明显差异(P>0.05),治疗后4周、8周,两组患者HAMD、SDRS评分差异具备统计学意义(P<0.05);观察组患者治疗总有效率为96.00%,对照组患者治疗总有效率为90.00%,观察组患者治疗效果明显优于对照组患者(P<0.05)。结论:认知疗法联合阿戈美拉汀治疗抑郁症患者的疗效更为显著,利于改善患者抑郁情况,提高患者临床治疗效果。
Objective:To observe the effect of cognitive therapy combined with agomelatine in the treatment of patients with depression.Methods:100 patients with depression treated in our hospital from February 2018 to February 2019 were selected,and all patients were divided into the control group(50 cases)and the observation group(50 cases).The control group was treated with agomelatine The patients in the observation group were treated with cognitive therapy combined with agomelatine.The HAMD and SDRS scores of the two groups of patients were compared,and the clinical treatment effects were compared.Results:Before treatment,there was no significant difference in HAMD and SDRS scores between the two groups of patients(P>0.05).At 4 and 8 weeks after treatment,the differences in HAMD and SDRS scores of the two groups were statistically significant(P<0.05).The total effective rate of treatment was 96.00%,and the total effective rate of treatment in the control group was 90.00%.The treatment effect of the observation group was significantly better than that of the control group(P<0.05).Conclusion:Cognitive therapy combined with agomelatine is more effective in treating patients with depression,which is conducive to improving the patient’s depression and clinical treatment.
作者
李晓华
LI Xiao-hua(Department of Psychiatrics,Liaocheng Fourth People’s Hospital,Liaocheng Shandong 252000,China)
出处
《医学食疗与健康》
2020年第3期7-7,9,共2页
Medical Diet and Health
关键词
认知疗法
阿戈美拉汀
抑郁症患者
Cognitive Therapy
Agomelatonin
Depression Patients
